Global study of Dexcom continuous glucose monitor in real life
Part of Hormones & metabolism clinical trials.
This trial is observing how well the Dexcom continuous glucose monitor (CGM) works for people in everyday life over a long period. It aims to understand the real-world benefits and outcomes of using this device to manage blood sugar levels.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be able to use the Dexcom CGM based on its official instructions.
- You need to have had an HbA1c blood test (a measure of average blood sugar) within the last 3 months.
- You must be willing to use the CGM and complete surveys about your experience.
- You need to follow the study plan and have at least one check-up with your doctor after starting the CGM.
- This trial is for people who are not already in another study that involves an experimental treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is a global registry that collects real-world information from people using the Dexcom Continuous Glucose Monitor (CGM). It helps researchers understand how the device works in everyday life, and it may help you manage your blood sugar better.
This study tests whether a continuous glucose monitor (CGM) helps people with type 2 diabetes who are not on insulin improve their blood sugar control. The CGM is a small sensor you wear that shows your sugar levels in real time, helping you and your care team make better decisions.
This study asks people with diabetes to use a continuous glucose monitor (a small device that tracks blood sugar automatically) and share their thoughts about it. Researchers want to understand what features matter most to patients and how well the device works in real life.
This study tests a continuous glucose monitor (a sensor that tracks glucose) for people with type 1 or type 2 diabetes who receive care at home through Mayo’s Advanced Care at Home program. It may help by improving how safely and accurately blood sugar is followed while you’re at home.
This trial tests a new continuous glucose monitor (CGM) designed to help manage blood sugar levels. You will wear the device for 15 days and attend three clinic visits to see how well it works.
This study tests a new continuous glucose monitor that checks your blood sugar levels in real time. It aims to see how accurate and safe it is for people with diabetes.
Hear when a new Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.